Authors of a pharmacist-directed transitions of care study discuss what drives pneumococcal vaccine hesitancy and how pharmacists can build systematic vaccine screening into inpatient workflows.
|Articles|December 13, 2021
Daily OTC Pearl: Blue Star Ointment
Author(s)Saro Arakelians, PharmD
Blue Star Ointment is used for skin issues such as itchiness, scaly, dry skin, eczema, rashes, ringworms, jock itch, and athlete’s foot.
Advertisement
OTC/Lifestyle Pearl of the Day: Blue Star Ointment
Indication: Blue Star Ointment is an OTC cream with
Insight:
- Blue Star Ointment is used for symptoms such as itchiness, scaly, dry skin, eczema, rashes, ringworms, jock itch, and athlete’s foot.
- It can relieve burning feeling and severe itchiness as well.
- Blue Star Ointment contains 1.2% camphor.
- The
American Academy of Dermatology Association recommends ointments or creams with camphor or menthol for relieving psoriasis-related itchiness. However, they also recommend using a moisturizer to counteract the drying effects of these products. - Patients should be advised to not get this in their eyes and to not ingest it.
Sources:
Advertisement
Related to this article
HYPERION trial data now support sotatercept within a patient's first year of pulmonary arterial hypertension (PAH) diagnosis, cutting clinical worsening risk by 76% compared with placebo.
A stewardship program combining EHR alerts and pharmacist-led education offers a replicable model for reducing bleeding risk.
Tim Cernohous of Cencora explains why patient trust no longer guarantees satisfaction—and how automation and better communication can close the gap with mail order.
Eight Humira biosimilars have been launched, but payer formularies and interchangeability rules decide what dispenses.
At NEIAP 2026, Kelsey Norman, PharmD, walked through how VESALIUS-CV, Lp(a)HORIZON, and CKM guidelines change pharmacist-led lipid care.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Findings presented at the European Respiratory Society Congress 2026 suggest semaglutide may offer respiratory benefits beyond its approved diabetes and obesity indications.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Bridging the Gap: Pharmacist Experiences Obtaining DEA Licenses
2
Armored CAR T-Cell Therapy Produces Durable Complete Response in Pediatric Solid Tumors
3
Eight Names, One Drug: Why Adalimumab Biosimilars Are Creating Real Confusion at the Counter
4
Expert Q&A: Pharmacists Address Pneumococcal Vaccine Hesitancy and Screening Complexity in Transitions of Care
5